Skip to main content

Table 4 Percent prevalence of HBV infection in patients of different diseases in Pakistan.

From: Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes

Population type Region Methods Population size HBV positive(%) HBV marker Reference
Surgical patients Karachi EIA 496 5.0% HBsAg Moosa et al. [57] 2009
  Jacobabad Sindh ICT 150 9.33% HBsAg Daudpota & Soomro, [58] 2008
  Karachi ELISA 387 6.5% HBsAg Masood et al. [59] 2005
  Karachi Latex method, ELISA 411 8.76% HBsAg Shirazi et al. [60] 2004
Patients with cirrhosis Saidu Sharif, Swat ELISA 110 21.81% HBsAg Khan et al. [62] 2009
  Dera Ismail Khan ICT 60 46.67% HBsAg Mashud et al. [63] 2004
  Lahore ICT, ELISA 94 23% HBsAg, anti-HBcIgG, anti-HBs, and HBeAg Khan et al. [64] 2002
  Lahore ELISA 50 24% HBsAg Hussain et al. [65] 1998
Patients with Hepatocellular carcinoma (HCC) Hyderabad ELISA 200 21.0% HBsAg Ansari et al. [66] 2009
  Rawalpindi ICT, ELISA 44 25% anti-HBsAg, anti-HBcAb antiHBeAb Mumtaz et al. [67] 2001
  Lahore ELISA 30 20% HBsAg Kausar et al. [68] 1998
Patients with hepatitis Rawalpindi ICT 264 9.8% HBsAg Mumtaz & Aftab [69] 2005
  Hyderabad/Jamshoro ELISA 100 41% anti-HBs
anti-HBc
Almani et al. [70] 2002
  Islamabad ELISA 2574 15% HBsAg Tanwani & Ahmad [71] 2000
  Karachi MEIA-Abbott 1225 2% HBsAg Mahmood [72] 2000
  Rawalpindi RPHA or ELISA 4315 11.68% HBsAg Hussain &
Ahmed [73] 1998
Patients of Liver disease Karachi ICT, ELISA, PCR 5193 32.6% HBsAg Ahmed et al. [74] 2010
  Peshawar ICT, ELISA and PCR. 181 18.23% HBs Ag or DNA Khan [75] 2006
  Faisalabad ELISA 100 29% HBsAg Bilal et al. [76] 2006
  Hazara Division ICT 893 30.35% HBsAg Khan and Rizvi [77] 2003
MTP (Thalassemic & Hemophiliac Children) Islamabad ICT, ELISA 251 3.9% HBsAg Burki et al. [79] 2009
  Peshawar ELISA 250 8.4% HBsAg Shah et al. [80] 2005
  Peshawar ELISA 80 7.591 HBsAg Mohammad et al. [81] 2003
  Peshawar ELISA 40 5% HBsAg Hussain et al. [82] 2003
Ophthalmic Patients Jamshoro/Hyderabad ICT 931 4.6% HBsAg Junejo et al. [88] 2009
  Dera Ismail Khan ICT, ELISA 1130 3.18% HBsAg Ahmad et al. [89] 2006
IDU Peshawar ELISA 250 22.4% HBsAg Alam et al. [86] 2007b
  Karachi ELISA 161 7.5% HBsAg Altaf et al. [87] 2007
  1. MTP: Multi-transfused Population, IDU: Injecting drug Users